- Home
- CHEC vs MBOT Comparison
CHEC vs MBOT Comparison
Compare CHEC & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.24
Company Overview
Basic Information| Metric | CHEC | MBOT |
|---|---|---|
| Founded | 2024 | 2010 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.4M | 166.6M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | CHEC | MBOT |
|---|---|---|
| Price | $10.09 | $2.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 6.3K | ★ 1.5M |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.91 | $1.60 |
| 52 Week High | $10.56 | $4.62 |
Technical Indicators
Market Signals| Indicator | CHEC | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 53.32 | 42.33 |
| Support Level | $9.93 | $1.99 |
| Resistance Level | $10.47 | $2.29 |
| Average True Range (ATR) | 0.03 | 0.13 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 11.76 | 14.81 |
Price Performance
Historical Comparison CHEC
MBOT
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.